Matches in Wikidata for { <http://www.wikidata.org/entity/Q80363605> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q80363605 description "artículu científicu espublizáu en mayu de 2007" @default.
- Q80363605 description "im Mai 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80363605 description "scientific article published on 01 May 2007" @default.
- Q80363605 description "wetenschappelijk artikel" @default.
- Q80363605 description "наукова стаття, опублікована в травні 2007" @default.
- Q80363605 name "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 name "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 type Item @default.
- Q80363605 label "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 label "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 prefLabel "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 prefLabel "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 P1433 Q80363605-FEE56F27-8372-4E39-87CC-8996422453F1 @default.
- Q80363605 P1476 Q80363605-46585F72-B4AE-4B00-9B0B-A8A165E8203F @default.
- Q80363605 P2093 Q80363605-0E38BEB7-A93D-40E0-80DE-A77B4E3F8794 @default.
- Q80363605 P2093 Q80363605-53FAFF9D-3100-462C-BF11-0C350D8288EA @default.
- Q80363605 P2093 Q80363605-541B1089-5815-4C38-8FA7-8CDC668BD99B @default.
- Q80363605 P2093 Q80363605-6692FCF6-50A4-4DBE-B8FC-65711AD73BD7 @default.
- Q80363605 P2093 Q80363605-FC1FDAEF-D4D9-4983-988A-6B947623A113 @default.
- Q80363605 P304 Q80363605-46BDF8CD-1184-4720-89AD-61B76BEF55C5 @default.
- Q80363605 P31 Q80363605-784CB905-2565-4FCC-AE94-D6F5525BB754 @default.
- Q80363605 P356 Q80363605-2AFCAE7F-827D-4898-BED3-0D1500385768 @default.
- Q80363605 P433 Q80363605-1AC58E0D-7265-4FE4-8695-4F3A76499399 @default.
- Q80363605 P478 Q80363605-3ABB1061-B35E-437E-88B6-F6449ADD06B6 @default.
- Q80363605 P50 Q80363605-3B3CA83C-4EC3-4DC2-A58B-AE3E7B5E1688 @default.
- Q80363605 P50 Q80363605-5A421D65-18ED-42E6-8D65-1694423F65F5 @default.
- Q80363605 P50 Q80363605-E2151A6E-EBAD-48B6-9EB6-C37D8C14EA8B @default.
- Q80363605 P577 Q80363605-1754738F-D413-4EA1-A7E9-470A09088C47 @default.
- Q80363605 P698 Q80363605-0AAA1D8A-C798-4356-AB13-D3EF3E4F51C2 @default.
- Q80363605 P356 ARDP.200600002 @default.
- Q80363605 P698 17516578 @default.
- Q80363605 P1433 Q10533542 @default.
- Q80363605 P1476 "The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones" @default.
- Q80363605 P2093 "Hana Divisová" @default.
- Q80363605 P2093 "Jarmila Kaustová" @default.
- Q80363605 P2093 "Josef Matyk" @default.
- Q80363605 P2093 "Karel Waisser" @default.
- Q80363605 P2093 "Petra Husáková" @default.
- Q80363605 P304 "264-267" @default.
- Q80363605 P31 Q13442814 @default.
- Q80363605 P356 "10.1002/ARDP.200600002" @default.
- Q80363605 P433 "5" @default.
- Q80363605 P478 "340" @default.
- Q80363605 P50 Q61053368 @default.
- Q80363605 P50 Q63663859 @default.
- Q80363605 P50 Q64495586 @default.
- Q80363605 P577 "2007-05-01T00:00:00Z" @default.
- Q80363605 P698 "17516578" @default.